Business● LowOct 30 · Oct 30, 2026, 12:26 PM
AbbVie posts Q3 beat as Skyrizi and Rinvoq offset Humira decline
GlobeAlert Desk · curated from Seeking Alpha Tech · global
AbbVie reported strong third-quarter earnings, with its drugs Skyrizi and Rinvoq compensating for a decrease in Humira sales. This reflects the company's financial performance and product portfolio dynamics.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business54m agoAsian stock markets climb after earlier tech routAl Jazeera [en]Business2h agoChina’s inflation edges lower in OctoberFinancial TimesBusiness2h agoLow pay, fatigue and staff shortages put Hong Kong’s aviation hub status at risk: unionsSouth China Morning PostBusiness2h agoPHINMA | Daily Tribunetribune.net.ph · Philippines